Clinical trial

The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in…

NCT00421460 · Chulalongkorn University, Other · Completed

Key facts

NCT number NCT00421460
Title The Therapy of Nebido as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction
Official title Phase IV Study of The Therapy of Long-acting Testosterone Undecanoate,1000mg in 4 ml Oily Solution for i.m.Injection(Nebido) as Mono or in Combination With PDE-5 Inhibitors in Hypogonadal Patients With Erectile Dysfunction
Lead sponsor Chulalongkorn University, Other
Collaborators Ramathibodi Hospital Siriraj Hospital
Status Completed
Phase Phase 4
Study type Interventional
Conditions Hypogonadism, Erectile Dysfunction
Intervention type Drug
Interventions Testosterone Undecanoate, 1000mg
Enrollment 30
Start date Jan 1, 2007
Primary completion Jan 1, 2011
Completion May 1, 2011
First posted Jan 12, 2007
Last update posted May 15, 2012
Countries Thailand

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies